Literature DB >> 19187264

Asymmetrical lateral ventricular enlargement in Parkinson's disease.

M M Lewis1, A B Smith, M Styner, H Gu, R Poole, H Zhu, Y Li, X Barbero, S Gouttard, M J McKeown, R B Mailman, X Huang.   

Abstract

BACKGROUND: A recent case report suggested the presence of asymmetrical lateral ventricular enlargement associated with motor asymmetry in Parkinson's disease (PD). The current study explored these associations further.
METHODS: Magnetic resonance imaging (3T) scans were obtained on 17 PD and 15 healthy control subjects at baseline and 12-43 months later. Baseline and longitudinal lateral ventricular volumetric changes were compared between contralateral and ipsilateral ventricles in PD subjects relative to symptom onset side and in controls relative to their dominant hand. Correlations between changes in ventricular volume and United Parkinson's disease rating scale motor scores (UPDRS-III) whilst on medication were determined.
RESULTS: The lateral ventricle contralateral to symptom onset side displayed a faster rate of enlargement compared to the ipsilateral (P = 0.004) in PD subjects, with no such asymmetry detected (P = 0.312) in controls. There was a positive correlation between ventricular enlargement and worsening motor function assessed by UPDRS-III scores (r = 0.96, P < 0.001). DISCUSSION: There is asymmetrical lateral ventricular enlargement that is associated with PD motor asymmetry and progression. Further studies are warranted to investigate the underlying mechanism(s), as well as the potential of using volumetric measurements as a marker for PD progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187264      PMCID: PMC2908273          DOI: 10.1111/j.1468-1331.2008.02430.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  37 in total

1.  Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients.

Authors:  K G Lloyd; H Möhler; P Heitz; G Bartholini
Journal:  J Neurochem       Date:  1975-12       Impact factor: 5.372

2.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.

Authors:  N J Cordato; C Pantelis; G M Halliday; D Velakoulis; S J Wood; G W Stuart; J Currie; M Soo; G Olivieri; G A Broe; J G L Morris
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

3.  The progression of Parkinson disease: a hypothesis.

Authors:  Anthony E Lang
Journal:  Neurology       Date:  2007-03-20       Impact factor: 9.910

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

Authors:  M T Hu; S J White; K R Chaudhuri; R G Morris; G M Bydder; D J Brooks
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

6.  Axial signs and magnetic resonance imaging correlates in Parkinson's disease.

Authors:  Hernish J Acharya; Thomas P Bouchard; Derek J Emery; Richard M Camicioli
Journal:  Can J Neurol Sci       Date:  2007-02       Impact factor: 2.104

7.  Hemisphere-Specific Effects of Subthalamic Nucleus Deep Brain Stimulation on Speaking Rate and Articulatory Accuracy of Syllable Repetitions in Parkinson's Disease.

Authors:  Emily Q Wang; Leo Verhagen Metman; Roy A E Bakay; Jean Arzbaecher; Bryan Bernard; Daniel M Corcos
Journal:  J Med Speech Lang Pathol       Date:  2006

8.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

9.  Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy.

Authors:  Christian Brenneis; Klaus Seppi; Michael F Schocke; Jörg Müller; Elisabeth Luginger; Sylvia Bösch; Wolfgang N Löscher; Christian Büchel; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

10.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

Authors:  M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  18 in total

1.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

2.  Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson's disease.

Authors:  Catherine C Price; Christopher Favilla; Jared J Tanner; Stephen Towler; Charles E Jacobson; Chris J Hass; Kelly D Foote; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2011-02-23       Impact factor: 4.891

3.  Side of motor onset is associated with hemisphere-specific memory decline and lateralized gray matter loss in Parkinson's disease.

Authors:  Eun-Young Lee; Suman Sen; Paul J Eslinger; Daymond Wagner; Lan Kong; Mechelle M Lewis; Guangwei Du; Xuemei Huang
Journal:  Parkinsonism Relat Disord       Date:  2015-02-18       Impact factor: 4.891

4.  Striatal shape in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Christopher Dimaio; Lan Kong; Paul J Eslinger; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2013-06-29       Impact factor: 4.673

5.  Contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of Parkinson's disease.

Authors:  Marcia C L Pereira; Mariane Secco; Daniela E Suzuki; Luciana Janjoppi; Carolina O Rodini; Layla B Torres; Bruno H S Araújo; Esper A Cavalheiro; Mayana Zatz; Oswaldo Keith Okamoto
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

6.  Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus.

Authors:  S H Lee; S S Kim; W S Tae; S Y Lee; J W Choi; S B Koh; D Y Kwon
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

7.  The Value of Shunt Surgery or Prophylactic Antiepileptic Therapy or Both in the Development of Dementia at Early Stages in Patients With Ventricular Dilatation.

Authors:  Konstantinos Faropoulos; Ourania Fotakopoulou; George Fotakopoulos
Journal:  Cureus       Date:  2022-05-28

8.  Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease.

Authors:  Anthony C Vernon; William R Crum; Saga M Johansson; Michel Modo
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

9.  Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline.

Authors:  Jiahui Wang; Clement Vachet; Ashley Rumple; Sylvain Gouttard; Clémentine Ouziel; Emilie Perrot; Guangwei Du; Xuemei Huang; Guido Gerig; Martin Styner
Journal:  Front Neuroinform       Date:  2014-02-06       Impact factor: 3.739

10.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

Authors:  Anthony C Vernon; Saga M Johansson; Michel M Modo
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.